/Investor DB

Cantos Ventures — 2019 Investments

5 investments dated 2019 · listed companies and verified rows first · show all

Concha Labsconchalabs.comin𝕏Pre-Seed · Aug 2019 · $500K

Concha Labs makes Concha Sol, an FDA-cleared over-the-counter self-fitting hearing aid that uses patented technology to personalize a user's sound profile, with a focus on hearing speech in noisy environments.

HardwareHealthtechMedical Devices

Amy Li(CEO & Founder)in

Co-investorsCreative Destruction Lab (CDL)Draper AssociatesGaingelsMedMountain VenturesStartXHyphen Capital

Ethycaethyca.comin𝕏Seed · Jul 2019 · $4M

Ethyca builds a "trusted data layer" for enterprises and AI, integrating privacy, data governance, and policy enforcement directly into systems to turn legal obligations into automated technical controls.

AI & Machine LearningCybersecurityData & InfrastructureEnterprise Software

Cillian Kieran(Founder)

Co-investorsAbstract VenturesAspenwoodAtlantic Vantage PointFounder CollectiveGood FriendsMiroma Ventures+3 more

Pow.Biopow.bioin𝕏Pre-Seed · Sep 2019 · $1.5M

Pow.Bio develops a high-efficiency continuous fermentation platform for biomanufacturing that enables production of biotech products at lower cost and faster timelines.

BiotechDeep Tech

Shannon Hall(Founder)inOuwei Wang(Founder)inOuwei Wang Shannon Hall(Founder)

Co-investorsBetter Ventures Central LlcGaingelsHitachi VenturesiSelect FundJuniperPossible Ventures+6 more

Shipamaxshipamax.comin𝕏Seed · Dec 2019Acquired

Shipamax provides automation technology for logistics organizations that reads logistics documents and converts them into machine-readable, business-ready data.

AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainSaaSLondon, GB

Jenna Brown(CEO)inFabian Blaicher(CTO)inJenna Blaicher-Brown(Founder)inNick Thorne(Head of Product)

BoardSimon Levene(Director)in

Co-investorsCrane Venture PartnersLong Venture PartnersMosaic VenturesY CombinatorAcequia Capital (AceCap)AME Cloud Ventures+9 more

XGenomesxgenomes.cominSeed · Sep 2019 · $3M

XGenomes develops DNA sequencing technology that combines novel biochemistry, hardware, and algorithms to sequence single molecules of DNA directly, without library preparation or a bioinformatics bottleneck.

AI & Machine LearningBiotechDeep TechDigital HealthHardwareHealthtechMedical DevicesBoston, US

Kalim Mir(CEO)inJaney Muñoz(Bio- and Systems Engineer)

Co-investorsFundersClubThink+ Ventures Management, LlcY CombinatorAmino CapitalFCVCHOF Capital+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.